Heathrow selects Smiths Detection for its next generation cabin baggage and security screening equipment
26.3.2021 10:00:00 EET | Business Wire | Press release
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has been chosen to supply integrated checkpoints throughout Heathrow Airport, featuring the HI-SCAN 6040 CTiX computed tomography X-rays, to deliver an advanced level of security and efficiency.
The ECAC EDS CB C3 approved CT systems will see Heathrow meet the highest regulatory requirements, while helping the leading airport achieve its vision for the future of the security checkpoint for passengers and colleagues. The integrated checkpoints feature iLane automatic tray return systems and Checkpoint.Evoplus, Smiths Detection’s checkpoint operation management solution. The award also includes a 10-year equipment service agreement.
“We are delighted to once again be given the opportunity to work closely with Heathrow Airport to provide leading-edge technologies that bring the best security outcomes and passenger experience,” said Smiths Detection President, Roland Carter. “Both Smiths Detection and Heathrow are focused on intelligent solutions that deliver efficiency, security and resilience; and these new lanes will allow for improvements to be easily integrated as technology develops.”
As part of its decision making, Heathrow sought a supplier that could deliver a large scale, innovative, end-to-end solution and integrate the lanes into the airports’ existing operational environment with no impact to capacity or passenger experience.
Each piece of the integrated checkpoint uses Smiths Detection’s leading-edge technology designed to help increase security, improve passenger experience, and enhance operational efficiency:
- HI-SCAN 6040 CTiX – This CT technology cabin baggage screening system provides the highest level of detection using 3D images with low false alarm rates. It delivers advanced explosives detection and can allow for electronics and liquids to remain in bags, helping to expedite the screening process.
- Checkpoint.Evoplus fully integrates the checkpoint by combining individual components of the lane onto a single, intelligent operational management solution. It enables centralised screening by delivering scanned images to operators based at separate locations, resulting in optimised resources management and reduced operational costs.
- iLane - a family of automatic tray return systems that use a modular smart lane design. By delivering a steady flow of trays, iLanes help remove bottlenecks and streamline the screening process to deliver higher throughput. The family includes iLane Selfcair, iLane.evo, and iLane.pro.
This contract is part of a long-term relationship between Heathrow and Smiths Detection, which includes the supply of industry leading hold baggage CT solutions.
The first lanes will be installed in anticipation of a recovery in passenger numbers later this year.
###
About Smiths Detection
Smiths Detection is a global leader in threat detection and screening technologies for aviation, ports and borders, urban security and defence. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.
Our mission is to help make the world a safer place – we do this by using technology to develop innovative solutions and services which protect life, safeguard society and uphold the free flow of trade.
For more information on Smiths Detection’s solutions and services, visit https://www.smithsdetection.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210326005015/en/
Contact information
Media Contacts
Tom Hufton / Georgina Reeves
FTI Consulting
sc.smithsdetection@fticonsulting.com
+44 (0)20 3727 1000
Sophie Mills
Global Communications Manager
Sophie.mills@smithsdetection.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 08:00:00 EEST | Press release
Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while differing based on the individual, are often similar among people alike in age, lifestyle, and environment.1 These results underscore the need for effective solutions that can be tailored to a wide variety of skin quality concerns. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706426842/en/ Key findings:1 Nine out of ten people globally are affected by skin quality concerns, with each person experiencing an average of two concerns in the past month The most common concerns are fine lines and wrinkles (41%), dry skin (40%), and dull skin (37%), most frequently affecting the face Skin quality impacts quality of life for 85% of people, with more than one in three reporting feelings of self-consciousness, insecurity or anxiety Skin
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 05:00:00 EEST | Press release
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing awareness of the connection between the gut and the brain, commonly referred to as the gut–brain axis. As a result, the g
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 03:00:00 EEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 02:00:00 EEST | Press release
Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Kath Harrison, Group President, International Growth at Real Chemistry. “By bringing Spurwing into Real Chemistry,
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
